Latest market price
249.57
-6.07-2.37%
CAHQT69Cardinal Health, Inc.·NYSE
249.57-2.37%
News
Down 2.4% — The Dividend Aristocrats Ranked By Quality Scores (October 2026) (seekingalpha.com).
Medium confidence
TA
Loading chart...
Screen all →
Snapshot
IndexS&P 500P/E34.52EPS (ttm)7.23Insider Own1.06%Shs Outstand231.56MPerf Week-1.77%
Market Cap57.79BForward P/E17.73EPS next Y14.08Insider Trans-10.24%Shs Float231.00MPerf Month12.11%
Enterprise Value62.64BPEG2.66EPS next Q-Inst Own-Short Float3.19%Perf Quarter8.82%
Income1.71BP/S0.23EPS this Y16.37%Inst Trans-Short Ratio3.71Perf Half Y24.88%
Sales254.25BP/B-EPS next Y12.23%ROA2.99%Short Interest7.37MPerf YTD21.45%
Book/sh-11.76P/C11.90EPS next 5Y12.98%ROE-59.73%52W High259.21 -3.72%Perf Year56.45%
Cash/sh20.97P/FCF12.77EPS past 3/5Y79.03% 28.30%ROIC13.24%52W Low158.70 57.26%Perf 3Y166.07%
Dividend Est.2.06 (0.83%)EV/EBITDA18.01Sales past 3/5Y7.44% 9.37%Gross Margin3.84%Volatility1.98% 2.31%Perf 5Y414.15%
Dividend TTM2.05 (0.82%)EV/Sales0.25EPS Y/Y TTM12.09%Oper. Margin1.03%ATR (14)5.56Perf 10Y231.26%
Dividend Ex-DateOct 01, 2026Quick Ratio0.49Sales Y/Y TTM14.23%Profit Margin0.67%RSI (14)60.38Recom2.45
Dividend Gr. 3/5Y0.91% 0.95%Current Ratio0.88EPS Q/Q23.83%SMA203.85%Beta0.53Target Price278.22
Payout28.65%Debt/Eq3.74Sales Q/Q6.15%SMA505.63%Rel Volume0.86Prev Close255.64
Employees61,344LT Debt/Eq-2.89EarningsNov 05SMA20012.89%Avg Volume1.82MPrice249.57
IPO DateAug 04, 1983Option/ShortYes / YesEPS/Sales Surpr.20.26% -2.27%Net Debt/EBITDA1.46Volume1,562,035Change-2.37%
Analyst Ratings
DateActionAnalystRatingTarget
Oct-20-26ReiteratedMizuhoOutperform$250 → $280
Oct-16-26ReiteratedUBSBuy$280 → $295
Aug-19-26ReiteratedRBC CapitalPerform$276
Aug-13-26ReiteratedBarclaysOverweight$258 → $275
Aug-12-26ReiteratedRobert W. Baird$251 → $274
Aug-12-26ReiteratedMorgan StanleyOverweight$255 → $265
Aug-12-26ReiteratedWells FargoOverweight$256 → $277
Aug-12-26ReiteratedUBSBuy$274 → $280
Aug-12-26ReiteratedMizuhoOutperform$235 → $250
Aug-12-26ReiteratedEvercore ISI GroupOutperform$240 → $270
Latest News· Times ET
Oct-23-26
Oct-20-26
Oct-19-26
Oct-15-26
Oct-13-26
Oct-08-26
Oct-06-26
Oct-05-26
Oct-02-26
Oct-01-26
Company

Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2026
6/30/2026
FY 2025
6/30/2025
FY 2024
6/30/2024
FY 2023
6/30/2023
FY 2022
6/30/2022
FY 2021
6/30/2021
FY 2020
6/30/2020
FY 2019
6/30/2019
Total Revenue254,248254,248222,578——————
Cost of Goods Sold Incl. D&A244,474244,474214,410——————
Gross Profit9,7749,7748,168——————
Selling, General and Administrative Excl. Other6,1326,1325,382——————
Research and Development
000——————
Other Operating Expense1,0291,029511——————
Operating Income2,6132,6132,275——————
Interest Expense348348215——————
Unusual Expense
—————————
Non-Operating Income (Expense)-91-9141——————
Net Income Before Taxes2,1742,1742,101——————
Income Taxes469469532——————
Consolidated Net Income1,7141,7141,561——————
Net Income From Continuing Operations1,7051,7051,569——————
Net Income1,7141,7141,561——————
EPS (Recurring)7.277.276.48——————
EPS (Basic, Before Extraordinaries)7.277.276.48——————
EPS (Diluted)7.237.236.45——————
EBITDA3,4783,4783,106——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio34.5232.8626.05——————
Price To Sales Ratio0.230.220.18——————
Gross Margin3.843.843.67——————
Operating Margin1.031.031.02——————
Net Margin0.670.670.70——————
Shares Outstanding236236241——————
Market Capitalization58,89956,06440,488——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$274.28$238.04$201.79$165.55$129.31● Close Price0.00M14.89M29.78M44.66M59.55MUSD Trades VolumeOctNovDec2026FebMarAprMayJunJulAugSepOct
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Scherer Mary C.Chief Accounting OfficerAug 19 '26Sale237.392,302546,4732,811Aug 20
Hollar Jason M.Chief Executive OfficerAug 19 '26Sale236.1844,52910,516,660190,603Aug 20
WEITZMAN DEBORAHCEO, PSS SegmentAug 18 '26Sale235.457,3541,731,52577,901Aug 20
Alt Aaron EChief Financial OfficerAug 18 '26Sale236.3442,0009,926,14020,495Aug 20
Mayer Jessica LChief Legal/Compliance OfficerAug 18 '26Sale236.1929,4366,952,48533,076Aug 20
Greene Michelle D.Chief Information OfficerAug 18 '26Sale235.7211,6502,746,18710,330Aug 20
Mason Stephen MCEO, GMPD SegmentAug 18 '26Sale236.4035,0008,274,11818,061Aug 20
Hollar Jason M.Chief Executive OfficerAug 18 '26Sale235.7480,00018,858,856235,132Aug 20
Greene Michelle D.Chief Information OfficerFeb 27 '26Sale228.472,746627,38712,230Mar 03
Alt Aaron EChief Financial OfficerFeb 18 '26Sale225.502,328524,96426,408Feb 18
Hall Patricia HemingwayDirectorFeb 06 '26Sale229.724,000918,88028,264Feb 10
WEITZMAN DEBORAHCEO, PSS SegmentAug 20 '25Sale150.5321,3673,216,37553,428Aug 20
Hollar Jason M.Chief Executive OfficerAug 20 '25Sale150.0435,9015,386,567200,000Aug 20
Mason Stephen MCEO, GMPD SegmentAug 19 '25Sale148.8241,5756,187,06326,085Aug 19
Scherer Mary C.Chief Accounting OfficerAug 19 '25Sale149.256,7661,009,8263,556Aug 19
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.